WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Stock Ownership - Who owns Trisalus Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trisalus Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David PatienceChief Financial Officer2026-07-0114,650$4.46
$65.34kSell
Richard MarshakChief Commercial Officer2026-06-30561$3.87
$2.17kBuy
Mary T. SzelaCEO and President2026-06-303,990$3.87
$15.44kBuy
Mats WahlstromDirector2026-05-1560,000$2.53
$151.80kBuy
Gary B. GordonDirector2026-05-1510,000$2.46
$24.60kBuy
Richard MarshakChief Commercial Officer2026-05-15543$2.67
$1.45kSell
David PatienceChief Financial Officer2026-05-157,100$2.43
$17.25kBuy
Michael P. StanskyDirector2026-05-15410,000$2.50
$1.03MBuy
Michael P. StanskyDirector2026-05-15200,000$2.50
$500.00kBuy
Mary T. SzelaCEO and President2026-05-1539,682$2.59
$102.78kBuy

1 of 4

TLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLSI insiders and whales buy or sell their stock.

TLSI Shareholders

What type of owners hold Trisalus Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Equity Ab Frankenius11.35%6,989,748$34.46MInsider
Medtech Acquisition Sponsor LLC10.15%6,249,999$30.81MInsider
Mats Wahlstrom4.81%2,962,030$14.60MInsider
Kerry R. Hicks3.76%2,317,400$11.42MInsider
Michael P. Stansky2.99%1,840,118$9.07MInsider
David J. Matlin2.15%1,323,210$6.52MInsider
Mary T. Szela1.75%1,077,683$5.31MInsider
Sean Murphy1.10%679,256$3.35MInsider
David Patience0.42%261,107$1.29MInsider
George Kelly Martin0.40%247,176$1.22MInsider

1 of 3

TLSI vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLSI0.04%41.05%Net BuyingNet Selling
MOBI0.03%30.73%Net BuyingNet Buying
CV0.01%26.78%Net BuyingNet Buying
CATX0.08%24.00%Net SellingNet Selling
TMCI0.05%74.24%Net BuyingNet Buying
View Top Medical Device Stocks

Trisalus Life Sciences Stock Ownership FAQ

Who owns Trisalus Life Sciences?

Trisalus Life Sciences (NASDAQ: TLSI) is owned by 0.04% institutional shareholders, 41.05% Trisalus Life Sciences insiders, and 58.91% retail investors. Equity Ab Frankenius is the largest individual Trisalus Life Sciences shareholder, owning 6.99M shares representing 11.35% of the company. Equity Ab Frankenius's Trisalus Life Sciences shares are currently valued at $34.95M.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.